Here's Won't Touch Teva: Why I Pass on the Generic Giant
Teva Pharmaceuticals sits at a crossroads of debt, generics, and a shifting pricing landscape. Here's why I won't tou...
Find out which is better for you: cash back or reward points. Make smart financial choices that suit your lifestyle today!
26,890 articlesTeva Pharmaceuticals sits at a crossroads of debt, generics, and a shifting pricing landscape. Here's why I won't tou...
When a mining stock pops today, investors sit up. Discover the drivers behind SSR Mining's rally, what it means for r...
Oil prices rose amid geopolitical tension and supply risks, signaling that prices could back toward the $5 gallon ran...
The Trump administration is weighing a measure to compensate TSA officers who have gone unpaid during a prolonged par...
Ford faces renewed scrutiny as recalls mount and U.S. sales soften, fueling a debate over whether ford should give ba...
A hotter-than-expected May PPI rekindles wholesale inflation back focus, sending Bitcoin lower as traders reassess in...
AI-driven capex sustains a two-horse race in semiconductors. This piece weighs which is the better semi stock to buy ...
New to crypto? This guide compares Bitcoin and XRP with actionable steps, real-world tips, and a straightforward plan...
If you’re weighing big tech bets, Microsoft often outshines Apple on value. This guide breaks down why MSFT stands as...
Over five years, SPDR’s XLK delivered a 35-point edge on the S&P 500, even as a Feb 2026 pullback tested investor ner...
Quantum computing is moving from labs to markets. This article pits Alphabet against IonQ to help you decide which mi...
A practical, investor-focused guide to vericel (vcel) 2025 earnings. Learn how revenue, margins, and milestones could...